Sandra Levy
ARTICLES BY THIS AUTHOR
- 12/21/2021
Camber launches generic Northera in 2 new dosage strengths
Camber's droxidopa capsules are now available in 100 mg, 200 mg and 300 mg strengths. - 12/21/2021
Retailers put limits in place for purchases of at-home COVID-19 tests
Walgreens, CVS, Rite Aid and Walmart are limiting the purchase of at-home COVID-19 tests due to high demand amid the spread of the omicron variant and the approaching holidays. - 12/21/2021
FDA approves Novadoz Pharmaceuticals' generic Gabitril, MSN's manufacturing facility
FDA gives Novadoz permission for generic Gabitril, as well as for MSN’s new state-of-the-art manufacturing facility. - 12/21/2021
FDA gives Pfizer EU authorization for Paxlovid
Pfizer's Paxlovid is indicated for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. - 12/21/2021
Aurobindo gets FDA OK for generic Bystolic
Nebivolol tablets have a market value of roughly $978 million for the 12 months ending October 2021, according to IQVIA. - 12/21/2021
Allergan debuts Vuity
Allergan’s Vuity is the first eye drop to treat presbyopia (age-related blurry near vision). - 12/20/2021
Hy-Vee to expand outside the Midwest
Hy-Vee is reportedly planning on opening a distribution center in Tennessee, and seven stores across Tennessee, Kentucky, Alabama and Indiana. - 12/20/2021
APhA names 2022 Immunization Champion Award winners
The Immunization Champion Awards recognizes individuals and organizations that have made extraordinary contributions toward improved vaccination rates within their communities. - 12/20/2021
Stop & Shop’s Nutrition Partners to host educational webinars in January
Stop & Shop’s Nutrition Partners will conduct small group discussions and provide nutrition guidance on how to find an eating pattern that consumers can stick to for success in 2022. - 12/20/2021
Eagle receives FDA approval for generic Vasostrict
Vasostrict had a market value of $786 million in 2020.
